Servier

Founded in 1954, Servier is an independent French pharmaceutical research company. Its development is based on the continuous pursuit of innovation in the therapeutic areas of cardiovascular, metabolic, neurologic, psychiatric, bone and joint diseases, as well as cancer. In 2013, the company recorded a turnover of 4.2 billion euros.

- 27% of turnover from Servier drugs were reinvested in Research and Development in 2013.

- With a strong international presence in 140 countries, Servier employs more than 21 000 people worldwide.

- 91% of Servier drugs are consumed outside of France.

- The Servier Group contributed 35% to the 2013 French trade surplus in the pharmaceuticals sector.